CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 30th Annual J.P. Morgan Healthcare Conference 2012 on Wednesday, January 11, 2012 at 7:30 a.m. PT (10:30 a.m. ET) at the Westin St. Francis in San Francisco, Calif. This presentation will include a review of the company's 2011 goals and its goals and guidance for 2012.
